Getinge (GETI-B.ST) Stock Analysis & AI Equity Report
Getinge (GETI-B.ST) overview
Getinge (GETI-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Getinge reported revenue of SEK 34,759m and operating profit of SEK 2,854m; the year-end share price was 181.55 SEK and market capitalisation was SEK 49,449m. Getinge is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Getinge's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-18. Data will be refreshed during report generation.
About Getinge
Getinge develops and sells equipment, systems and services for hospitals and life science institutions, with offerings across intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Its portfolio includes ventilators, anesthesia and operating room equipment, sterilization systems, and digital workflow solutions designed to improve clinical results and hospital efficiency.
Generate the Getinge report
Getinge is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Getinge and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.